Europe Animal Healthcare Market Growth Accelerated by Increasing Companion Animal Ownership
The Europe Animal Healthcare Market is an important market
due to the increasing pet adoption rates over the past few years. Animal
healthcare products such as vaccines, parasiticides & anti-infectives,
medicines and feed additives provide veterinary care for companion animals as
well as livestock. They are essential in maintaining the health of animals and
preventing the spread of zoonotic diseases. The global Europe Animal Healthcare
Market is estimated to be valued at US$ 14,096.3 Mn in 2023 and is expected to
exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in
a new report published by Coherent Market Insights.
Market key trends:
The increasing pet adoption across Europe has been a major factor driving the
growth of the animal healthcare market over the past decade. According to
European Pet Food Industry Federation, the total pet population in Europe has
grown from 135 million in 2008 to 165 million in 2020. This growing companion
animal ownership has augmented the demand for animal healthcare products like
vaccines and parasiticides to safeguard the health of pets. As people increasingly
view pets as companion and family members, they are willing to spend more on
animal care, which is benefitting the market growth. Furthermore, rising
awareness about animal welfare has also propelled the need for quality
veterinary care and healthcare products for both companion and livestock
animals in the region.
Segment Analysis
The Europe
animal healthcare market is segmented by animal type into companion animals
and livestock animals. The companion animal segment accounts for the dominating
share of the market owing to increasing pet adoption, rising awareness
regarding pet healthcare, and growing expenditure on pet care products. Within
companion animals, dogs hold the largest market share due to high adoption
rates and availability of easy-to-administer products by key players for canine
healthcare.
Key Takeaways
The global Europe animal healthcare market is expected to witness high growth
during the forecast period.
Regional analysis showed that Germany accounted for the
largest share of the Europe animal healthcare market in 2024. Factors such as
increasing adoption of companion animals, growing pet healthcare expenditure,
and a high number of veterinarians contributed to Germany's leading position.
Key players operating in the Europe animal healthcare market
are Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol
S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG,
and Archer Daniels Midland Company. Merck & Co., Inc. specializes in development
and supply of veterinary prescription medicines, vaccines, and health
management solutions. Zoetis Inc. offers pet care products such as
parasiticides, vaccines, and medical devices. Dechra Pharmaceuticals Plc.
focuses on development, manufacturing, and supply of veterinary pharmaceuticals
and related products for Europe and international markets.

Comments
Post a Comment